BPO TV

Previous

7th July 2025

From the helm: Proteomics International (ASX:PIQ), Dr. Richard Lipscombe, Managing Director

In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests.

In this video, Dr. Lipscombe covers:

  • (0:47): An overview of PIQ and its FY26 goals
  • (1:38): The significance of three world-first blood tests
  • (5:26): The global addressable markets for these conditions
  • (6:25): Clinical trial progress and commercialisation roadmap
  • (8:14): How the diagnostic tests work and deliver value to patients
  • (9:16): Commercialisation strategy across key regions
  • (11:23): Additional assets in the PIQ pipeline
  • (12:36): What investors can expect over the next 12 months

Note: This interview was recorded on 3 July 2025.